FI20020333A0 - Metyloidun syklodekstriinin uudet kompleksit - Google Patents
Metyloidun syklodekstriinin uudet kompleksitInfo
- Publication number
- FI20020333A0 FI20020333A0 FI20020333A FI20020333A FI20020333A0 FI 20020333 A0 FI20020333 A0 FI 20020333A0 FI 20020333 A FI20020333 A FI 20020333A FI 20020333 A FI20020333 A FI 20020333A FI 20020333 A0 FI20020333 A0 FI 20020333A0
- Authority
- FI
- Finland
- Prior art keywords
- cyclodextrin
- novel complexes
- methylated cyclodextrin
- beta
- directed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20020333A FI20020333A0 (fi) | 2002-02-20 | 2002-02-20 | Metyloidun syklodekstriinin uudet kompleksit |
| ES03702684T ES2301780T3 (es) | 2002-02-20 | 2003-02-20 | Nuevos complejos de ciclodextrina metilada. |
| US10/505,122 US7423026B2 (en) | 2002-02-20 | 2003-02-20 | Methylated cyclodextrin complexes |
| NZ535153A NZ535153A (en) | 2002-02-20 | 2003-02-20 | Novel methylated cyclodextrin complexes |
| AT03702684T ATE391138T1 (de) | 2002-02-20 | 2003-02-20 | Neue komplexe methylierter cyclodextrine |
| CA2476833A CA2476833C (en) | 2002-02-20 | 2003-02-20 | Novel methylated cyclodextrin complexes |
| EP03702684A EP1476472B1 (en) | 2002-02-20 | 2003-02-20 | Novel methylated cyclodextrin complexes |
| AU2003205807A AU2003205807B2 (en) | 2002-02-20 | 2003-02-20 | Novel methylated cyclodextrin complexes |
| DE60320088T DE60320088T2 (de) | 2002-02-20 | 2003-02-20 | Neue komplexe methylierter cyclodextrine |
| PCT/FI2003/000125 WO2003070774A1 (en) | 2002-02-20 | 2003-02-20 | Novel methylated cyclodextrin complexes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20020333A FI20020333A0 (fi) | 2002-02-20 | 2002-02-20 | Metyloidun syklodekstriinin uudet kompleksit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI20020333A0 true FI20020333A0 (fi) | 2002-02-20 |
Family
ID=8563271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20020333A FI20020333A0 (fi) | 2002-02-20 | 2002-02-20 | Metyloidun syklodekstriinin uudet kompleksit |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7423026B2 (fi) |
| EP (1) | EP1476472B1 (fi) |
| AT (1) | ATE391138T1 (fi) |
| AU (1) | AU2003205807B2 (fi) |
| CA (1) | CA2476833C (fi) |
| DE (1) | DE60320088T2 (fi) |
| ES (1) | ES2301780T3 (fi) |
| FI (1) | FI20020333A0 (fi) |
| NZ (1) | NZ535153A (fi) |
| WO (1) | WO2003070774A1 (fi) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110433133A (zh) * | 2019-08-19 | 2019-11-12 | 中国人民解放军军事科学院军事医学研究院 | 治疗创伤后应激障碍的大麻二酚鼻用制剂 |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI113340B (fi) * | 2002-02-20 | 2004-04-15 | Tomi Jaervinen | Uudet luonnon syklodekstriinin kompleksit |
| GB0329918D0 (en) * | 2003-12-24 | 2004-01-28 | West Pharm Serv Drug Res Ltd | Intranasal compositions |
| CN101203208A (zh) * | 2005-06-20 | 2008-06-18 | 尤尼麦德制药公司 | 屈大麻酚治疗偏头痛 |
| LT2280687T (lt) * | 2008-03-26 | 2019-08-26 | Stichting Sanammad | Kramtomosios gumos kompozicijos, apimančios kanabinoidus |
| US8735374B2 (en) * | 2009-07-31 | 2014-05-27 | Intelgenx Corp. | Oral mucoadhesive dosage form |
| US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
| US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
| PL2643022T3 (pl) | 2010-11-25 | 2018-12-31 | Aop Orphan Pharmaceuticals Ag | Szybko rozpadające się kompozycje zawierające Nabilon i losowo metylowaną beta cyklodekstrynę |
| US20170340562A9 (en) * | 2014-05-12 | 2017-11-30 | Hddc Holdings Llc | Cannabinoid caffeinated drinks, powder, beans, and cannabinoid loose tea leaf |
| US9744128B2 (en) | 2014-06-05 | 2017-08-29 | Mastix LLC | Method for manufacturing medicated chewing gum without cooling |
| JP7053054B2 (ja) | 2016-04-15 | 2022-04-12 | エスアールイー ウェルネス，インク． | 大麻注入甘味料及び他の組成物 |
| JP2019511580A (ja) | 2016-04-15 | 2019-04-25 | エスアールイー ウェルネス インク．Ｓｒｅ Ｗｅｌｌｎｅｓｓ Ｉｎｃ． | 乳化剤を使用して大麻油を親水性にする方法及び関連するカンナビノイド組成物 |
| US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
| US10765658B2 (en) | 2016-06-22 | 2020-09-08 | Mastix LLC | Oral compositions delivering therapeutically effective amounts of cannabinoids |
| CA3036585A1 (en) * | 2016-09-27 | 2018-04-05 | CannTab Therapeutics Limited | Sustained release cannabinoid formulations |
| US11097206B2 (en) | 2016-12-09 | 2021-08-24 | Orochem Technologies Inc. | Method for producing purified steviol product using simulated moving bed chromatography |
| US10058531B1 (en) | 2017-06-01 | 2018-08-28 | Spartak LLC | Dosage delivery film |
| HRP20220277T1 (hr) | 2017-09-28 | 2022-05-13 | Zynerba Pharmaceuticals, Inc. | Liječenje fragilnog x sindroma i autizma kanabidiolom |
| US11179340B2 (en) * | 2017-12-29 | 2021-11-23 | TGC Network LLC | Cannabidiol dosage form |
| MX2020007483A (es) * | 2018-01-13 | 2020-11-12 | Pure Green Pharmaceuticals Inc | Transformacion de aceites de canabidiol y terpeno en polvos secos hidrosolubles para suministro sublingual de forma solida. |
| US20200016091A1 (en) * | 2018-07-16 | 2020-01-16 | Orochem Technologies, Inc. | Water-soluble cannabidiol |
| WO2020028897A1 (en) * | 2018-08-03 | 2020-02-06 | Lilu's Garden, Ltd. | CONSTRUCT OF β-CYCLODEXTRIN AND CANNABINOID GUEST COMPLEX AND PROCESSES FOR PRODUCING A PASTE COMPRISING THE SAME |
| MX2021007076A (es) | 2018-12-14 | 2021-08-11 | Zynerba Pharmaceuticals Inc | Tratamiento para el sindrome de supresion del 22q11.2 con cannabidiol. |
| US11660283B2 (en) | 2018-12-19 | 2023-05-30 | Joyn Botanicals Ltd. | Cannabinoid-containing composition |
| CN110123876A (zh) * | 2019-05-30 | 2019-08-16 | 汉义生物科技（北京）有限公司 | 一种含有非精神活性大麻素的包合物及其制备方法 |
| CN110204426B (zh) * | 2019-07-02 | 2023-05-30 | 梁志全 | 一种水溶性cbd的制备方法及水溶性cbd |
| WO2021081140A1 (en) * | 2019-10-21 | 2021-04-29 | Esolate Ltd | Superfine compounds and production thereof |
| WO2021123874A1 (en) | 2019-12-16 | 2021-06-24 | Pisak Mehmet Nevzat | Cannabinoid compositions with high solubility and bioavailabilty |
| WO2021144262A1 (de) * | 2020-01-13 | 2021-07-22 | Rrw B.V. | Wässrige lösung einer lipophilen verbindung |
| EP3919046A1 (en) | 2020-06-02 | 2021-12-08 | Athenion AG | Method for solubilizing natural, endogenous and synthetic cannabinoids |
| CN114748429A (zh) * | 2020-12-29 | 2022-07-15 | 汉义生物科技（北京）有限公司 | 一种水溶性大麻素制剂及其制备方法 |
| WO2024097327A1 (en) * | 2022-11-02 | 2024-05-10 | Progressive Therapeutics, Inc. | Cannabinoid formulations and use for treatment of emotional disorders and sexual dysfunction |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU194858B (en) | 1982-12-03 | 1988-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them |
| US4596795A (en) | 1984-04-25 | 1986-06-24 | The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services | Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives |
| US5180716A (en) | 1990-08-01 | 1993-01-19 | The Regents Of The University Of California | Cyclodextrin complexes for neuraxial administration of drugs |
| GB9726916D0 (en) | 1997-12-19 | 1998-02-18 | Danbiosyst Uk | Nasal formulation |
| CA2463687A1 (en) | 2001-10-18 | 2003-04-24 | Decode Genetics Ehf | Cyclodextrin complexes |
| FI113340B (fi) | 2002-02-20 | 2004-04-15 | Tomi Jaervinen | Uudet luonnon syklodekstriinin kompleksit |
-
2002
- 2002-02-20 FI FI20020333A patent/FI20020333A0/fi unknown
-
2003
- 2003-02-20 EP EP03702684A patent/EP1476472B1/en not_active Expired - Lifetime
- 2003-02-20 US US10/505,122 patent/US7423026B2/en not_active Expired - Fee Related
- 2003-02-20 NZ NZ535153A patent/NZ535153A/xx not_active IP Right Cessation
- 2003-02-20 WO PCT/FI2003/000125 patent/WO2003070774A1/en active IP Right Grant
- 2003-02-20 DE DE60320088T patent/DE60320088T2/de not_active Expired - Lifetime
- 2003-02-20 ES ES03702684T patent/ES2301780T3/es not_active Expired - Lifetime
- 2003-02-20 AT AT03702684T patent/ATE391138T1/de not_active IP Right Cessation
- 2003-02-20 AU AU2003205807A patent/AU2003205807B2/en not_active Ceased
- 2003-02-20 CA CA2476833A patent/CA2476833C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110433133A (zh) * | 2019-08-19 | 2019-11-12 | 中国人民解放军军事科学院军事医学研究院 | 治疗创伤后应激障碍的大麻二酚鼻用制剂 |
Also Published As
| Publication number | Publication date |
|---|---|
| DE60320088D1 (de) | 2008-05-15 |
| US7423026B2 (en) | 2008-09-09 |
| ATE391138T1 (de) | 2008-04-15 |
| EP1476472B1 (en) | 2008-04-02 |
| CA2476833A1 (en) | 2003-08-28 |
| AU2003205807A1 (en) | 2003-09-09 |
| WO2003070774A1 (en) | 2003-08-28 |
| EP1476472A1 (en) | 2004-11-17 |
| AU2003205807B2 (en) | 2008-11-20 |
| US20050090468A1 (en) | 2005-04-28 |
| DE60320088T2 (de) | 2009-06-04 |
| ES2301780T3 (es) | 2008-07-01 |
| CA2476833C (en) | 2011-02-01 |
| NZ535153A (en) | 2006-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI20020333A0 (fi) | Metyloidun syklodekstriinin uudet kompleksit | |
| FI20020334A0 (fi) | Luonnon syklodekstriinin uuden kompleksit | |
| ECSP056111A (es) | Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica | |
| CY1105836T1 (el) | 12, 13-τροποποιημενα παραγωγα εποθιλονης | |
| DE60106954D1 (de) | Resorcin-derivate | |
| CY1112560T1 (el) | Πνευμονικη μεταφορα των αμινογλυκοσιδων | |
| BR0207278A (pt) | Derivados de ftalazinona-piperidina como inibidores de pde4 | |
| DK1446387T3 (da) | Substituerede aryl, 1,4-pyrazinderivater | |
| MXPA03010134A (es) | Derivados de ciclohexan-1-4-diamina sustituidos. | |
| UY27346A1 (es) | Composiciones farmaccuticas que contienen conjuntos de polemero y frrmaco. | |
| NO20032788L (no) | Modafinil-forbindelse og cyklodekstrinblandinger | |
| NO20014756D0 (no) | C(10)-heterosubstituerte acetattaksaner som antitmormidler | |
| IL152892A0 (en) | Cannabinoid drugs | |
| MXPA05002489A (es) | Composiciones para el cuidado personal basadas en alcohol ramificado. | |
| EA200200313A1 (ru) | Применение доцетаксела для лечения печеночно-клеточного рака | |
| TR200102742T2 (tr) | Rezorsinol türevleri | |
| DK1204659T3 (da) | Serotonerge benzofuraner | |
| HUP0402628A2 (hu) | Helyettesített benzopiránok, mint szelektív ösztrogénreceptor-béta agonisták | |
| ATE280169T1 (de) | Serotonerge benzothiophene | |
| TR200402030T4 (tr) | İkame edilen I-aminobutan-3-ol-türevleri | |
| ATE427970T1 (de) | Verbesserte mikrogele und filme | |
| ATE483714T1 (de) | Podophyllotoxine als antiproliferative mittel | |
| NO20014758L (no) | C(7)-heterosubstituerte acetattaxaner som antitumormidler | |
| ATE256124T1 (de) | Substituierte benzimidazole, ihre herstellung und ihre verwendung als mittel gegen parasitäre protozoen | |
| BR0013084A (pt) | Heterociclil-2h-cromenos substituìdos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer of assignment of patent |
Owner name: PEDIPHARM OY Free format text: PEDIPHARM OY |